论文部分内容阅读
目的探讨在治疗儿童反复呼吸道感染时采用联合用药模式的效果。方法 110例患儿,随机分为对比组与研究组,各55例。对比组为患儿单纯提供匹多莫德进行治疗,研究组患儿采用匹多莫德联合玉屏风口服液治疗。观察两组临床疗效。结果研究组患儿治疗总有效率为96.36%(53/55),明显高于对比组81.82%(45/55)(P<0.05);同时研究组患儿治疗后两种血清免疫球蛋白(IgG和IgA)含量均明显高于对比组(P<0.05);随访3个月后,研究组反复感染次数为(1.03±0.28)次,对比组为(1.79±0.42)次,研究组反复感染次数明显低于对比组,差异具有统计学意义(P<0.05)。结论采用联合用药方式能够有效提升儿童反复呼吸道感染的治疗效果,并降低患儿反复感染率。
Objective To explore the effect of combination therapy in the treatment of recurrent respiratory tract infections in children. Methods 110 cases of children were randomly divided into control group and study group, each 55 cases. The control group was treated with Pidotimod alone, and the study group was treated with Pidotimod and Yupingfeng oral liquid. The clinical effects of two groups were observed. Results The total effective rate of treatment group was 96.36% (53/55), which was significantly higher than that of the control group (81.82%, 45/55) (P <0.05). At the same time, the serum immunoglobulin (1.03 ± 0.28) times in the study group and (1.79 ± 0.42) times in the control group, the study group was infected repeatedly (P <0.05) The number of times was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion The combination therapy can effectively improve the therapeutic effect of recurrent respiratory tract infections in children and reduce the recurrent infection rate in children.